Three CIHR Grants Awarded!
Congrats to Maziar Divangahi and Faiz Ahmad Khan on their Fall 2020 Project Grants and Benjamin M Smith on his COPD Catalyst Grant
Maziar Divangahi
View his faculty profile here: Maziar Divangahi, PhD
Associate Professor, Department of Medicine, McGill University
Associate Director, Meakins-Christie Laboratories
Research Theme: Host defense against pulmonary pathogens; regulation of death program in macrophages
Keywords: innate and adaptive immunity • influenza virus • mycobacterium tuberculosis • cell death program
View Maziar Divangahi’s recent posts and news below.
Flu Vaccines and COVID-19
Dr. Maziar Divangahi on how flu vaccines can help train our body’s immunity to fight the COVID-19 virus.
Cracking the Code of Stem Cells in TB
Congratulations to Dr. Nargis Khan and Jeffrey Downey from the Divangahi lab on their recent publication in Cell!
Innate Disease Tolerance and COVID-19
Could Dr. Divangahi’s expertise in innate disease tolerance be applied to the SARS CoV-2 virus, enabling us to co-exist?
Flu Vaccines May Inhibit COVID-19
Dr. Divangahi discusses ongoing studies that examine whether flu vaccines may inhibit COVID-19.
Royal Society of Canada Class of 2020
The Royal Society of Canada announces Dr. Maziar Divangahi as one of its newest members to the College of New Scholars
COVID-19 and Disease Tolerance
Dr. Irah King discusses disease tolerance in light of the recent COVID-19 pandemic and why some weather the infection unscathed
Defeating SARS-CoV-2: A Team Effort
Dr. Maziar Divangahi asserts that only a team effort across scientific disciplines will lead to the elimination of SARS-CoV-2.
Using β-glucan to Help Fight TB Infection
Dr. Nargis Khan and Dr. Eva Kaufmann from the Divangahi lab publish their work in Cell Reports
Five CIHR Project Grants Awarded!
Congratulations to all Meakins and RECRU members who were funded in the Fall 2019 Project Grant Competition!
- « Previous
- 1
- 2
- 3
- 4
- Next »